FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:2086 December 19, 2002 Number 25 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Alcohol is the most prevalent human teratogen. Fetal alcohol spectrum disorder is estimated to affect up to 1 percent of infants born in North America. The ascertainment of gestational exposure to alcohol is paramount for the diagnosis of the disorder. It is widely recognized that maternal reporting results in underestimates of the prevalence and amount of exposure to alcohol.

Until recently, there have been no objective biologic markers for the detection of long-term in utero exposure to alcohol. Studies in adults have documented that circulating ethanol is transesterified with fatty acids to fatty acid ethyl esters.¹ On . . . [Full Text of this Article]

This article has been cited by other articles:

• KULAGA, V., CAPRARA, D., IQBAL, U., KAPUR, B., KLEIN, J., REYNOLDS, J., BRIEN, J., KOREN, G. (2006). FATTY ACID ETHYL ESTERS (FAEE); COMPARATIVE ACCUMULATION IN HUMAN AND GUINEA PIG HAIR AS A BIOMARKER FOR PRENATAL ALCOHOL EXPOSURE. Alcohol Alcohol 41: 534-539 [Abstract] [Full Text]  
• Sokol, R. J., Delaney-Black, V., Nordstrom, B. (2003). Fetal Alcohol Spectrum Disorder. JAMA 290: 2996-2999 [Full Text]  
• Chan, D., Klein, J., Koren, G. (2003). New Methods for Neonatal Drug Screening. NeoReviews 4: e236-244 [Full Text]